Strengthening Competitive Edge and Driving Innovation CS MEDICA announces the achievement of its fourth European patent, this time for its Psoriasis Gel, which is already MDR-approved. This milestone underscores the company’s dedication to delivering innovative, science-backed treatments and further solidifies its competitive edge in the MedTech sector. The patent reinforces …
